Acquired by Thoma Bravo in Nov 2023
NXGN - NextGen Healthcare, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Atlanta,
United States
Type: Equity
NXGN price evolution
NXGN
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $58.78 | $77.91 | $105.99 | |
| Short term investments | $146.43 | $147.77 | $139.61 | |
| Net receivables | $89.28 | $84.12 | $88.5 | |
| Inventory | ||||
| Total current assets | $362.8 | $374.73 | $401.82 | |
| Long term investments | ||||
| Property, plant & equipment | $7.55 | $8.69 | $9.76 | |
| Goodwill & intangible assets | $406.36 | $405.29 | $405.24 | |
| Total noncurrent assets | $494.95 | $493.74 | $494.28 | |
| Total investments | $146.43 | $147.77 | $139.61 | |
| Total assets | $857.75 | $868.47 | $896.1 | |
| Current liabilities | ||||
| Accounts payable | $10.47 | $12.18 | $12.02 | |
| Deferred revenue | $45.93 | $48.35 | $61.6 | |
| Short long term debt | $3.47 | $3.49 | $3.83 | |
| Total current liabilities | $143.88 | $167.84 | $198.11 | |
| Long term debt | $270.03 | $270.52 | $270.94 | |
| Total noncurrent liabilities | $290.6 | $290.11 | $297.56 | |
| Total debt | $273.5 | $274.01 | $274.76 | |
| Total liabilities | $434.48 | $457.95 | $495.67 | |
| Shareholders' equity | ||||
| Retained earnings | $138.81 | $133.75 | $127.6 | |
| Other shareholder equity | -$1.58 | -$2.24 | -$1.46 | |
| Total shareholder equity | $423.27 | $410.52 | $400.44 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $105.99 | $66.75 | $78.58 | $140.32 |
| Short term investments | $139.61 | |||
| Net receivables | $88.5 | $76.06 | $77.54 | $80.01 |
| Inventory | ||||
| Total current assets | $401.82 | $211.57 | $207.64 | $260.01 |
| Long term investments | ||||
| Property, plant & equipment | $9.76 | $20.44 | $32.98 | $50.84 |
| Goodwill & intangible assets | $405.24 | $335.47 | $345.39 | $361.98 |
| Total noncurrent assets | $494.28 | $416.1 | $436.84 | $460.1 |
| Total investments | $139.61 | |||
| Total assets | $896.1 | $627.67 | $644.49 | $720.12 |
| Current liabilities | ||||
| Accounts payable | $12.02 | $9.13 | $11.38 | $10.52 |
| Deferred revenue | $61.6 | $61.28 | $52.86 | $56.79 |
| Short long term debt | $3.83 | $8.09 | $12.73 | $10.62 |
| Total current liabilities | $198.11 | $180.86 | $180.63 | $143.22 |
| Long term debt | $270.94 | $11.93 | $18.45 | $167.82 |
| Total noncurrent liabilities | $297.56 | $23.73 | $32.21 | $176.4 |
| Total debt | $274.76 | $20.02 | $31.19 | $178.44 |
| Total liabilities | $495.67 | $204.6 | $212.84 | $319.62 |
| Shareholders' equity | ||||
| Retained earnings | $127.6 | $130.25 | $128.63 | $119.12 |
| Other shareholder equity | -$1.46 | -$1.91 | -$1.92 | -$2.14 |
| Total shareholder equity | $400.44 | $423.08 | $431.64 | $400.49 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $176.42 | $178.21 | $178.55 | |
| Cost of revenue | $94.8 | $98.39 | $94.03 | |
| Gross Profit | $81.62 | $79.82 | $84.52 | |
| Operating activities | ||||
| Research & development | $18.02 | $20.93 | $20.03 | |
| Selling, general & administrative | $54.17 | $48.19 | $83.33 | |
| Total operating expenses | $73.56 | $70.75 | $108.43 | |
| Operating income | $8.06 | $9.07 | -$23.91 | |
| Income from continuing operations | ||||
| EBIT | $10.01 | $11.79 | -$21.36 | |
| Income tax expense | $1.64 | $2.39 | $0.48 | |
| Interest expense | $3.31 | $3.24 | $3.4 | |
| Net income | ||||
| Net income | $5.05 | $6.16 | -$25.24 | |
| Income (for common shares) | $5.05 | $6.16 | -$25.24 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $596.35 | $556.82 | $540.24 | |
| Cost of revenue | $295.4 | $275.42 | $267.44 | |
| Gross Profit | $300.95 | $281.4 | $272.8 | |
| Operating activities | ||||
| Research & development | $76.66 | $75.5 | $83.3 | |
| Selling, general & administrative | $209.66 | $180.53 | $165.17 | |
| Total operating expenses | $294.29 | $268.58 | $267.69 | |
| Operating income | $6.66 | $12.82 | $5.11 | |
| Income from continuing operations | ||||
| EBIT | $6.7 | $12.79 | $6.21 | |
| Income tax expense | $3.58 | -$0.24 | -$3.24 | |
| Interest expense | $1.5 | $3.52 | $1.96 | |
| Net income | ||||
| Net income | $1.62 | $9.52 | $7.5 | |
| Income (for common shares) | $1.62 | $9.52 | $7.5 | |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | $5.05 | $6.16 | -$25.24 | $7.82 |
| Operating activities | ||||
| Depreciation | $9.69 | $9.69 | $10.38 | $9.41 |
| Business acquisitions & disposals | -$3.85 | -$47.45 | ||
| Stock-based compensation | $9.43 | $8.17 | $6.57 | $8.82 |
| Total cash flows from operations | -$9.42 | -$8.1 | $7.68 | $2.18 |
| Investing activities | ||||
| Capital expenditures | -$9.6 | -$8.68 | -$8.3 | -$9.12 |
| Investments | $2.39 | -$8.01 | -$139.58 | |
| Total cash flows from investing | -$7.2 | -$16.69 | -$151.73 | -$56.57 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.78 | $0.65 | $1.44 | -$37.18 |
| Net borrowings | $266.52 | |||
| Total cash flows from financing | -$2.43 | -$3.25 | $0.57 | $225.48 |
| Effect of exchange rate | -$0.08 | -$0.05 | $0 | $0.07 |
| Change in cash and equivalents | -$19.12 | -$28.08 | -$143.48 | $171.16 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$2.65 | $1.62 | $9.52 | $7.5 |
| Operating activities | ||||
| Depreciation | $39.41 | $48.05 | $56 | $55.9 |
| Business acquisitions & disposals | -$40.05 | -$0.21 | -$71.69 | |
| Stock-based compensation | $32.41 | $27.2 | $23.51 | $19.64 |
| Total cash flows from operations | $43.66 | $53.55 | $98.52 | $85.6 |
| Investing activities | ||||
| Capital expenditures | -$37.26 | -$28.08 | -$28.34 | -$26.88 |
| Investments | -$139.58 | |||
| Total cash flows from investing | -$216.89 | -$28.08 | -$28.55 | -$96.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$43.04 | -$30.86 | $3.48 | $2.41 |
| Net borrowings | $266.52 | -$130.42 | $118 | |
| Total cash flows from financing | $212.62 | -$37.29 | -$131.72 | $116.27 |
| Effect of exchange rate | -$0.15 | |||
| Change in cash and equivalents | $39.24 | -$11.83 | -$61.74 | $105.8 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.24 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |